Distribution of sotrovimab paused in certain US states

Mar 25, 2022

The Office of the Assistant Secretary for Preparedness and Response has announced that it will pause the distribution of sotrovimab in certain US states in which the BA.2 variant has become the dominant COVID-19 strain.  This announcement follows FDA advice which indicates that sotrovimab is not effective against the BA.2 variant.

Print Page Mail Article